×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CRVO – cervomed inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CRVO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/4
05:00 pm
crvo
CervoMed Announces Late-Breaking Data at the 18th CTAD Conference Demonstrating Neflamapimod Significantly Slows Clinical Progression in Dementia with Lewy Bodies
Low
Report
CervoMed Announces Late-Breaking Data at the 18th CTAD Conference Demonstrating Neflamapimod Significantly Slows Clinical Progression in Dementia with Lewy Bodies
12/2
09:04 am
crvo
CervoMed (NASDAQ:CRVO) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $31.00 price target on the stock.
Medium
Report
CervoMed (NASDAQ:CRVO) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $31.00 price target on the stock.
12/2
07:00 am
crvo
CervoMed Presents New Plasma Biomarker Data That Indicates Neflamapimod Broadly Improves Neuroinflammation and Neurodegeneration in Dementia with Lewy Bodies (DLB)
Medium
Report
CervoMed Presents New Plasma Biomarker Data That Indicates Neflamapimod Broadly Improves Neuroinflammation and Neurodegeneration in Dementia with Lewy Bodies (DLB)
11/24
07:00 am
crvo
CervoMed to Share New Data on Neflamapimod as a Treatment for Dementia with Lewy Bodies at the 18th Clinical Trials on Alzheimer's Disease (CTAD) Conference
Medium
Report
CervoMed to Share New Data on Neflamapimod as a Treatment for Dementia with Lewy Bodies at the 18th Clinical Trials on Alzheimer's Disease (CTAD) Conference
11/11
08:09 am
crvo
CervoMed (NASDAQ:CRVO) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $31.00 price target on the stock.
Medium
Report
CervoMed (NASDAQ:CRVO) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $31.00 price target on the stock.
11/10
07:00 am
crvo
CervoMed Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
Low
Report
CervoMed Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
11/5
07:19 am
crvo
CervoMed (NASDAQ:CRVO) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating.
Low
Report
CervoMed (NASDAQ:CRVO) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating.
11/4
08:42 am
crvo
CervoMed (NASDAQ:CRVO) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $31.00 price target on the stock.
Medium
Report
CervoMed (NASDAQ:CRVO) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $31.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/19
07:46 am
crvo
Form 4 CervoMed Inc. For: Nov 17 Filed by: Gregoire Sylvie
Low
Report
Form 4 CervoMed Inc. For: Nov 17 Filed by: Gregoire Sylvie
11/19
07:46 am
crvo
Form 4 CervoMed Inc. For: Nov 17 Filed by: Winton Matthew
Low
Report
Form 4 CervoMed Inc. For: Nov 17 Filed by: Winton Matthew
11/19
07:45 am
crvo
Form 4 CervoMed Inc. For: Nov 17 Filed by: ALAM JOHN J
Low
Report
Form 4 CervoMed Inc. For: Nov 17 Filed by: ALAM JOHN J
11/19
07:45 am
crvo
Form 4 CervoMed Inc. For: Nov 17 Filed by: ELDER WILLIAM ROBERT
Low
Report
Form 4 CervoMed Inc. For: Nov 17 Filed by: ELDER WILLIAM ROBERT
11/17
09:02 am
crvo
Form 4 CervoMed Inc. For: Nov 13 Filed by: Gregoire Sylvie
Medium
Report
Form 4 CervoMed Inc. For: Nov 13 Filed by: Gregoire Sylvie
11/17
09:01 am
crvo
Form 4 CervoMed Inc. For: Nov 13 Filed by: ALAM JOHN J
Medium
Report
Form 4 CervoMed Inc. For: Nov 13 Filed by: ALAM JOHN J
11/17
09:01 am
crvo
Form 4 CervoMed Inc. For: Nov 14 Filed by: Winton Matthew
Medium
Report
Form 4 CervoMed Inc. For: Nov 14 Filed by: Winton Matthew
11/13
08:52 am
crvo
Form 4 CervoMed Inc. For: Nov 12 Filed by: ALAM JOHN J
Low
Report
Form 4 CervoMed Inc. For: Nov 12 Filed by: ALAM JOHN J
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: